Church & Dwight (NYSE:CHD – Get Free Report) had its target price hoisted by TD Cowen from $114.00 to $117.00 in a report issued on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s target price indicates a potential upside of 13.69% from the company’s previous close.
Several other equities analysts have also recently issued reports on the company. Barclays boosted their target price on Church & Dwight from $82.00 to $86.00 and gave the company an “underweight” rating in a research note on Friday, October 11th. Truist Financial reduced their target price on Church & Dwight from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, August 5th. Piper Sandler started coverage on Church & Dwight in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $120.00 price target on the stock. Evercore ISI reduced their price target on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a research note on Monday, August 5th. Finally, Morgan Stanley cut Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 price target on the stock. in a research note on Monday, September 9th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $108.10.
View Our Latest Stock Analysis on Church & Dwight
Church & Dwight Trading Down 1.8 %
Church & Dwight (NYSE:CHD – Get Free Report) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.68 by $0.11. Church & Dwight had a return on equity of 19.86% and a net margin of 13.38%. The firm had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the company posted $0.74 earnings per share. The business’s revenue was up 3.8% on a year-over-year basis. As a group, equities research analysts expect that Church & Dwight will post 3.43 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the business. Capital Performance Advisors LLP bought a new position in shares of Church & Dwight during the third quarter valued at $27,000. Crewe Advisors LLC bought a new position in Church & Dwight in the first quarter valued at about $28,000. Rothschild Investment LLC bought a new position in Church & Dwight in the second quarter valued at about $31,000. Point72 Asia Singapore Pte. Ltd. bought a new position in Church & Dwight in the second quarter valued at about $33,000. Finally, Strategic Financial Concepts LLC bought a new position in Church & Dwight in the second quarter valued at about $38,000. 86.60% of the stock is owned by institutional investors.
Church & Dwight Company Profile
Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.
Read More
- Five stocks we like better than Church & Dwight
- Top Biotech Stocks: Exploring Innovation Opportunities
- Intel: Is Now the Time to Be Brave?
- Following Congress Stock Trades
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What Are Growth Stocks and Investing in Them
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Church & Dwight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Church & Dwight and related companies with MarketBeat.com's FREE daily email newsletter.